Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / NONOF - Terns Pharmaceuticals: A Risky Buy Ahead Of Q4 Obesity, Oncology Catalysts

NONOF - Terns Pharmaceuticals: A Risky Buy Ahead Of Q4 Obesity, Oncology Catalysts

Novo Nordisk - Class B

2025-07-11 11:27:44 ET

Terns Overview - Two Key Candidates With Data Catalysts In Q4, Funding Into 2028

For further details see:

Terns Pharmaceuticals: A Risky Buy Ahead Of Q4 Obesity, Oncology Catalysts

Stock Information
Company Name: Novo Nordisk - Class B
Stock Symbol: NONOF
Market: OTC
Website: novonordisk.com
Menu
Get NONOF Alerts

News, Short Squeeze, Breakout and More Instantly...